Manipulating quorum sensing system to control pathogenicity in Vibrio cholerae
操纵群体感应系统控制霍乱弧菌的致病性
基本信息
- 批准号:8749228
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-16 至 2019-09-15
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgonistAmino AcidsBacteriaBehaviorBindingBiochemicalBiological AssayCell CommunicationCell Signaling ProcessCell physiologyCellsCholeraCommunitiesDetectionDevelopmentDiarrheaDigestive System DisordersDiseaseGeneticGoalsHumanIn VitroInfectionLigandsMapsMembraneMicrobial BiofilmsMolecularMutagenesisN-(3-oxohexanoyl)-3-aminodihydro-2(3H)-furanonePathogenicityPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPopulation DensityProductionPublic HealthSeriesSignal TransductionSignaling MoleculeSourceSpecificityStomachStructureSynthesis ChemistrySystemTherapeuticVibrioVibrio choleraeVirulenceVirulence Factorsextracellulargenetic analysisin vivoinsightinterestnovel therapeuticspathogenpathogenic bacteriapublic health relevancequorum sensingreceptorresearch studyresponsesensorsensor histidine kinase
项目摘要
DESCRIPTION (provided by applicant): The overarching goal of this study is to understand the molecular mechanisms underpinning bacterial collective behaviors required for causing acute gastric infections in humans. To explore this, quorum sensing, the process of cell-cell communication in the pathogenic bacterium Vibrio cholerae will be studied. V. cholerae is the etiological agent of the disease cholera, a severe diarrheal condition that is a source of enormous public health concern in the developing world. Quorum sensing in V. cholerae depends on the production, release, detection, and response to extracellular signaling molecules called autoinducers. Group-wide detection of autoinducers allows V. cholerae to synchronously alter its behavior in response to changes in the population density and species composition of the vicinal bacterial community. In V. cholerae, quorum sensing is activated by two autoinducers, CAI-1 and AI-2. CAI-1, the dominant signal, is detected by the membrane-bound histidine sensor kinase, CqsS, and these are the focus of this study. In V. cholerae, quorum sensing represses biofilm formation and virulence factor production. Thus, molecules that activate quorum sensing ("pro-quorum sensing" molecules) have the potential to repress virulence in V. cholerae and to be developed into therapeutics. The goal of this study is to define
the molecular mechanism by which specific molecules are recognized by the CqsS receptor and determine how they elicit the quorum sensing response. Particularly interesting are ligand- receptor interactions between CqsS and the recently discovered CqsS agonist called WYZ301. WYZ301 is structurally distinct from CAI-1 and yet it potently agonizes quorum sensing. Studying new molecules, such as WYZ301, should greatly enhance the understanding of how CqsS interacts with ligands to generate the quorum sensing response. More generally, these studies will contribute to the development of novel therapeutics for V. cholerae, closely related pathogenic vibrios, as well as other diarrhea-causing bacteria that use quorum sensing for collective behaviors, including virulence.
描述(由申请人提供):本研究的总体目标是了解引起人类急性胃感染所需的细菌集体行为的分子机制。为了探索这一点,我们将研究致病菌霍乱弧菌中细胞间通讯的群体感应过程。霍乱弧菌是霍乱病的病原体,霍乱是一种严重的腹泻病,是发展中国家巨大的公共卫生问题的根源。霍乱弧菌的群体感应取决于称为自诱导剂的细胞外信号分子的产生、释放、检测和响应。群体范围内的自诱导剂检测使霍乱弧菌能够同步改变其行为,以响应邻近细菌群落的种群密度和物种组成的变化。在霍乱弧菌中,群体感应由两种自诱导剂 CAI-1 和 AI-2 激活。 CAI-1 是主要信号,由膜结合组氨酸传感器激酶 CqsS 检测,这些是本研究的重点。在霍乱弧菌中,群体感应抑制生物膜形成和毒力因子产生。因此,激活群体感应的分子(“原群体感应”分子)有可能抑制霍乱弧菌的毒力并被开发成治疗药物。本研究的目标是定义
CqsS 受体识别特定分子并决定它们如何引发群体感应反应的分子机制。特别有趣的是 CqsS 和最近发现的称为 WYZ301 的 CqsS 激动剂之间的配体-受体相互作用。 WYZ301 在结构上与 CAI-1 不同,但它能有效地抑制群体感应。研究新分子(例如 WYZ301)应该会极大地增强对 CqsS 如何与配体相互作用以产生群体感应响应的理解。更一般地说,这些研究将有助于开发针对霍乱弧菌、密切相关的致病性弧菌以及其他利用群体感应进行集体行为(包括毒力)的腹泻细菌的新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alice Kyungsun Min其他文献
Alice Kyungsun Min的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alice Kyungsun Min', 18)}}的其他基金
Manipulating quorum sensing system to control pathogenicity in Vibrio cholerae
操纵群体感应系统控制霍乱弧菌的致病性
- 批准号:
8921990 - 财政年份:2013
- 资助金额:
$ 4.77万 - 项目类别:
Manipulating quorum sensing system to control pathogenicity in Vibrio cholerae
操纵群体感应系统控制霍乱弧菌的致病性
- 批准号:
9139459 - 财政年份:2013
- 资助金额:
$ 4.77万 - 项目类别:
Manipulating quorum sensing system to control pathogenicity in Vibrio cholerae
操纵群体感应系统控制霍乱弧菌的致病性
- 批准号:
9335347 - 财政年份:2013
- 资助金额:
$ 4.77万 - 项目类别:
Manipulating quorum sensing system to control pathogenicity in Vibrio cholerae
操纵群体感应系统控制霍乱弧菌的致病性
- 批准号:
8649279 - 财政年份:2013
- 资助金额:
$ 4.77万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别: